Skip to main content
. 2012 Jul 10;36(5):437–448. doi: 10.1111/j.1365-2036.2012.05208.x

Figure 2.

Figure 2

Mean number of hours of lost workplace productivity at baseline and Week 12 for the placebo (PBO) and alosetron treatment groups. BL, baseline; QD, once daily; BID, twice daily. *P < 0.05, ***P < 0.001, significantly different from placebo.